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Cystic fibrosis-related diabetes (CFRD) is a common co-morbidity
among people with CF (PwCF) and is associated with weight loss,
protein catabolism, lung function decline, and increased mortality.
Nutritional status and pulmonary function begin to decline in
PwCF several years before the diagnosis of CFRD. Early CFRD
detection and aggressive insulin therapy have been shown to
reduce the mortality gap between PwCF who have CFRD and
those who do not. The Clinical Care Guidelines for Cystic FibrosisRelated Diabetes recommend annual screening for people with CF
starting at age 10.1 In 2011, team members at Children’s Mercy
Kansas City (CMKC) embarked on a quality improvement (QI)
project focused on improving oral glucose tolerance test (OGTT)
completion rates in PwCF.

Due to the lack of a standardized process and education, previous OGTT screening
rates were poor: 9% in 2008, 13% in 2009 and 25% in 2010. During the first year of
standard interventions (2011), the rate rose to 77%. By identifying barriers and
standardizing our process, OGTT completion rates have continued to rise. In 2019,
OGTT completion rate was 92% and in 2020, despite the COVID-19 pandemic,
which eliminated 3 months of testing opportunities, the completion rate was 81%.
In recent years, endocrinology has partnered with the CF Team in monthly
CF/Endocrinology “combo clinics” which allow PwCF who have impaired glucose
tolerance or CFRD to be evaluated by an endocrinology provider during their
routine CF clinic visit.

This QI project was initiated in 2011 and quality improvement
work has continued to the present day. Despite the COVID-19
pandemic, OGTT completion rates have remained high. By the
end of the third quarter or 2021, the completion rate was 68%
with an anticipated completion rate of 90%
Education of PwCF and their families regarding the importance of
annual testing, patient tracking, coordination of OGTTs with
annual laboratory testing during routine clinic appointments and
commitment to sustained quality have allowed CMKC to attain
high rates of OGTT completion. Earlier identification of impaired
glucose tolerance and CFRD has allowed for more timely
interventions, including dietary modifications, exercise
recommendations, endocrinology involvement in the plan of care,
home monitoring of blood glucose and implementation of insulin
therapy when necessary.
OGTT completion rates have been further impacted by
standardized clinic depart paperwork, the launch of a hospitalwide patient portal and the addition of morning clinic
appointment spaces; these changes have allowed for easier
communication and greater scheduling availability.

During the initial phase of this project, QI methodology
including fishbone diagrams and process flowcharts were
employed to identify barriers to obtaining OGTTs.
Subsequently, the following steps were implemented:
 Patient education materials (English and Spanish) were
developed and distributed annually
 A database for tracking was developed
 Upcoming appointments were reviewed to avoid missed
testing opportunities
 OGTTs were completed with annual laboratory testing at
routine clinic appointments, at the end of a hospitalization, or
at a local lab facility based on patient preference
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